Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.41 |
| ▸ | TSHR | P16473 | 4/20 | 0.38 |
| ▸ | MGAM | O43451 | 2/20 | 0.35 |
| ▸ | GAA | P10253 | 2/20 | 0.35 |
| ▸ | SI | P14410 | 2/20 | 0.35 |
| ▸ | MGAM2 | Q2M2H8 | 2/20 | 0.35 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.35 |
| ▸ | TET2 | Q6N021 | 1/20 | 0.33 |
| ▸ | RECQL | P46063 | 1/20 | 0.32 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.30 |
| ▸ | FFAR3 | O14843 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL25006073 | 0.92 | ALDH1A1 (0.42) | ALDH1A1TSHRMGAMGAASI | |
| SCHEMBL3710659 | 0.92 | ALDH1A1 (0.48) | ALDH1A1TSHRMGAMGAASI | |
| Sulfuric Acid SCHEMBL27755738 | 0.89 | ALDH1A1 (0.35) | ALDH1A1TSHRGAA | |
| SCHEMBL5580162 | 0.87 | KDM4E (0.35) | ALDH1A1TSHRMGAMGAASI | |
| SCHEMBL19471793 | 0.87 | TSHR (0.44) | ALDH1A1TSHRGAARECQL | |
| SCHEMBL16787359 | 0.86 | — | — | |
| SCHEMBL7764684 | 0.86 | — | — | |
| SCHEMBL6228119 | 0.85 | ALDH1A1 (0.68) | ALDH1A1TSHRMGAMGAASI | |
| SCHEMBL2639426 | 0.84 | — | — | |
| SCHEMBL407825 | 0.83 | ALDH1A1 (0.31) | ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 204 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9878975-B2 | Catalytic hydrogenation for producing amines from carboxylic acid amides, carboxylic acid diamides, di-, tri-, or polypeptides, or peptide amides | EVONIK DEGUSSA GMBH (DE) | 2018-01-30 | — | — | US | claimed |
| US-5614217-A | Capsule shell formulation to produce brittle capsules | R.P. SCHERER CORPORATION (US) | 1997-03-25 | — | — | US | claimed |
| US-4766149-A | SYNERGISTIC MIXTURE WITH ANTITUMOR AND ANTICARCINOGENIC AGENTS | STIFTUNG DEUTSCHES KREBSFORSCHUNGSZENTRUM (DE) | 1988-08-23 | — | — | US | claimed |
| EP-0007597-B1 | N-LOWERALKYL-GLYCINAMIDES AND SARCOSINE ANHYDRIDE AND THEIR MIXTURES WITH KNOWN TUMOR-INHIBITING COMPOUNDS, SARCOSIN FOR USE IN THE TREATMENT OF TUMORS, MEDICAMENTS CONTAINING THESE COMPOUND AND PROCESSES FOR THEIR PREPARATION | Stiftung Deutsches Krebsforschungszentrum (DE) | 1985-01-16 | — | — | EP | claimed |
| US-20240148683-A1 | STABLE PHARMACEUTICAL COMPOSITION AND METHODS OF USING SAME | AMARIN PHARMACEUTICALS IRELAND LIMITED (IE) | 2024-05-09 | — | — | US | disclosed |
| WO-2024058984-A2 | METHODS AND USES OF MICROBIOME COMPOSITIONS, COMPONENTS, OR METABOLITES FOR TREATING INSULIN-ASSOCIATED DISEASES | MarvelBiome, Inc. (US) | 2024-03-21 | — | — | WO | disclosed |
| US-11905527-B2 | Gel composition for culturing cells, production method thereof, method for culturing cells, and substrate for culturing cells | SHIMADZU CORPORATION (JP) | 2024-02-20 | — | — | US | disclosed |
| US-20240016803-A1 | PHARMACEUTICAL COMPOSITION COMPRISING EICOSAPENTAENOIC ACID AND DERIVATIVES THEREOF AND A STATIN | AMARIN PHARMACEUTICALS IRELAND LIMITED (IE) | 2024-01-18 | — | — | US | disclosed |
| WO-2023074090-A1 | CELL CULTURING CONTAINER, CELL CULTURING METHOD, AND METHOD FOR MANUFACTURING CELL CULTURING CONTAINER | 株式会社島津製作所 | 2023-05-04 | — | — | WO | disclosed |
| EP-2958926-B1 | EPIDITHIODIOXOPIPERAZINE COMPOUND OR ITS DERIVATIVES, AND THE USE THEREOF | VASTHERA CO LTD (KR) | 2023-03-08 | — | — | EP | disclosed |
| US-11547710-B2 | Pharmaceutical composition comprising eicosapentaenoic acid and derivatives thereof and a statin | AMARIN PHARMACEUTICALS IRELAND LIMITED (IE) | 2023-01-10 | — | — | US | disclosed |
| US-11537045-B2 | Photosensitive compositions and applications thereof | PROMERUS, LLC (US) | 2022-12-27 | — | — | US | disclosed |
| US-5171688-A | Multizonal; enzymatic oxidation to produce peroxide which oxidizes dye to product detectable product | CHOLESTECH CORPORATION (US) | 1992-12-15 | — | — | US | disclosed |
| US-5156954-A | Hydrogen peroxide generated by reaction of analyte in the presence of oxidase converts substrate reagent to colored reaction product | CHOLESTECH CORPORATION (US) | 1992-10-20 | — | — | US | disclosed |
| US-5110724-A | Drop-size blood sample | CHOLESTECH CORPORATION (US) | 1992-05-05 | — | — | US | disclosed |
| US-4766149-A | SYNERGISTIC MIXTURE WITH ANTITUMOR AND ANTICARCINOGENIC AGENTS | STIFTUNG DEUTSCHES KREBSFORSCHUNGSZENTRUM (DE) | 1988-08-23 | — | — | US | disclosed |
| US-4766149-A | SYNERGISTIC MIXTURE WITH ANTITUMOR AND ANTICARCINOGENIC AGENTS | STIFTUNG DEUTSCHES KREBSFORSCHUNGSZENTRUM (DE) | 1988-08-23 | — | — | US | disclosed |
| US-4766149-A | SYNERGISTIC MIXTURE WITH ANTITUMOR AND ANTICARCINOGENIC AGENTS | STIFTUNG DEUTSCHES KREBSFORSCHUNGSZENTRUM (DE) | 1988-08-23 | — | — | US | disclosed |
| EP-0007597-B1 | N-LOWERALKYL-GLYCINAMIDES AND SARCOSINE ANHYDRIDE AND THEIR MIXTURES WITH KNOWN TUMOR-INHIBITING COMPOUNDS, SARCOSIN FOR USE IN THE TREATMENT OF TUMORS, MEDICAMENTS CONTAINING THESE COMPOUND AND PROCESSES FOR THEIR PREPARATION | Stiftung Deutsches Krebsforschungszentrum (DE) | 1985-01-16 | — | — | EP | disclosed |
| EP-0007597-A1 | N-loweralkyl-glycinamides and sarcosine anhydride and their mixtures with known tumor-inhibiting compounds, sarcosin for use in the treatment of tumors, medicaments containing these compound and processes for their preparation | Stiftung Deutsches Krebsforschungszentrum (DE) | 1980-02-06 | — | — | EP | disclosed |